Phase 3 Trial of mRNA-1273 during the Delta-Variant Surge
Lindsey R. Baden, Hana M. El Sahly, Brandon Essink, Dean Follmann, Kathleen M. Neuzil, Allison August, Heather Clouting, Gabrielle Fortier, Weiping Deng, Shu Han, Xiaoping Zhao, Brett Leav, Carla Talarico, Bethany Girard, Yamuna Devi Paila, Joanne E. Tomassini, F. Schödel, Rolando Pajón, Honghong Zhou, Rituparna Das, Jacqueline M. Miller
Abstract
mRNA-1273 Vaccine Efficacy against the Delta Variant Participants who had received placebo in a previous phase of this trial were offered the mRNA-1273 vaccine in the open-label phase. The incidenc...
Topics & Concepts
Messenger RNAPlaceboPhase (matter)DeltaMedicineInternal medicineVirologyBiologyChemistryGeneticsPhysicsGenePathologyAstronomyOrganic chemistryAlternative medicineSARS-CoV-2 and COVID-19 ResearchViral Infections and Immunology ResearchVirus-based gene therapy research